“…Finally, CAP could be categorized into four stages: stage 0—no plaque (TPV 0, PAV 0); stage 1—mild plaque (a mostly non-obstructive disease; TPV 0–250 mm 3 , PAV 0–5%); stage 2—moderate plaque (a combination of one vessel disease and non-obstructive disease; 250–750 mm 3 , PAV 5–15%); and stage 3—severe plaque (a multivessel disease with majority ischemic; TPV > 750 mm 3 , PAV > 15%) [ 5 ]. Other authors have used CCTA to report similar findings regarding the significance of LD-NCP and plaque characteristics with ischemia [ 6 ]. The study by the ICONIC investigators showed that through CCTA analysis, it was feasible to demonstrate volumetric differences in the composition of CAP, paving the way for the earlier detection of at-risk lesions prior to the future development of ACS [ 7 ].…”